Technologies Fueling Biopharma and Life Sciences Research

Technologies Fueling Biopharma and Life Sciences Research

RELEASE DATE
03-Nov-2017
REGION
Global
Research Code: D758-00-5F-00-00
SKU: HC02916-GL-TA_21052
$250.00
In stock
SKU
HC02916-GL-TA_21052
$250.00
DownloadLink

Pay by invoice

ENQUIRE NOW

Description

This edition of the Genetic Technology TOE depicts life sciences trends across the biopharmaceutical industry. Different genetic technologies, antibody drug conjugates, mitochondrial based therapies are illustrated. The corresponding clinical trials scenario is depicted, along with the industry interactions.

The Genetic Technology TechVision Opportunity Engine (TOE) presents the latest R&D developments and advances with an emphasis on opportunities to profit in the explosive field of genetic technology through technology transfer, joint ventures, and acquisitions. The complete gamut of genetic technology applications is covered including the latest developments in omics technologies; genetic, cellular, and alternative therapies; sequencing technologies; and genetically altered animals and plants.

The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare.

Keywords: Gene therapy, high-grade glioma, Risankizumab, antibody drug conjugate, mitochondrial network, healthy aging

Table of Contents

Recent Advances in Biopharma and Life Sciences Technologies

  • Gene Therapy Advancement for High-Grade Glioma (HGG)
  • Positive Phase-3 Results for Risankizumab
  • Daiichi Sankyo and Glycotope Collaborate for Antibody Drug Conjugate (ADC) Development
  • Role of Mitochondrial Networks in Healthy Aging

Clinical Trial Analysis and Industry Interactions

  • Key Clinical Studies Conducted by Tocagen Inc.
  • Key Clinical Studies Conducted by Tocagen Inc.
  • Summary of Key Contacts
Related Research
This edition of the Genetic Technology TOE depicts life sciences trends across the biopharmaceutical industry. Different genetic technologies, antibody drug conjugates, mitochondrial based therapies are illustrated. The corresponding clinical trials scenario is depicted, along with the industry interactions. The Genetic Technology TechVision Opportunity Engine (TOE) presents the latest R&D developments and advances with an emphasis on opportunities to profit in the explosive field of genetic technology through technology transfer, joint ventures, and acquisitions. The complete gamut of genetic technology applications is covered including the latest developments in omics technologies; genetic, cellular, and alternative therapies; sequencing technologies; and genetically altered animals and plants. The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare. Keywords: Gene therapy, high-grade glioma, Risankizumab, antibody drug conjugate, mitochondrial network, healthy aging
More Information
No Index No
Podcast No
Industries Healthcare
WIP Number D758-00-5F-00-00
Is Prebook No
Ti Codes D758